M. Fang

H. Deeg, Emily A. Stevens, B. Wood, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117.

C. Bloomfield, F. Appelbaum, R. Stone, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic Syndrome.

B. Wood, B. Sandmaier, T. Gooley, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Genomic differences between estrogen receptor (ER)‐positive and ER‐negative human breast carcinoma identified by single nucleotide polymorphism array comparative genome hybridization analysis

J. Davison, K. Claffey, S. Tannenbaum, 2011, Cancer.

Positron Emission Tomography/Magnetic Resonance Imaging Radiomics in Predicting Lung Adenocarcinoma and Squamous Cell Carcinoma

Changfeng Yuan, Luoyu Wang, X. Ge, 2022, Frontiers in Oncology.

A National Multicenter Evaluation of the Clinical Utility of Optical Genome Mapping for Assessment of Genomic Aberrations in Acute Myeloid Leukemia

J. Broach, R. Kanagal-Shamanna, B. Levy, 2020, medRxiv.

Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma.

R. Storb, B. Sandmaier, D. Maloney, 2017, Blood advances.

Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016.

Sonali M. Smith, J. Friedberg, J. Leonard, 2015, Blood.

Evidence-based review of genomic aberrations in diffuse large B cell lymphoma, not otherwise specified (DLBCL, NOS): Report from the cancer genomics consortium lymphoma working group.

T. N. Senaratne, J. Fink, S. Mathew, 2022, Cancer genetics.

AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report

Emily A. Stevens, J. Radich, B. Wood, 2020, Biomarker Research.

Impact of Pre-Transplant Measurable Residual Disease on Outcome of Allogeneic Hematopoietic Cell Transplantation in Adult Monosomal Karyotype AML

B. Wood, R. Storb, B. Sandmaier, 2020, Leukemia.

Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation

B. Wood, B. Sandmaier, B. Storer, 2012, Cancer.

Impact of residual normal metaphases in core binding factor acute myeloid leukemia

E. Estey, F. Appelbaum, M. Othus, 2012, Cancer.

Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation.

E. Estey, B. Sandmaier, B. Storer, 2011, Blood.

Influence of residual normal metaphases in acute myeloid leukemia patients with monosomal karyotype

E. Estey, F. Appelbaum, M. Othus, 2011, Haematologica.

Additional Analyses of a Randomized Phase II Study of Azacitidine Combined with Lenalidomide or with Vorinostat Vs. Azacitidine Monotherapy in Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML): North American Intergroup Study SWOG S1117

C. Bloomfield, F. Appelbaum, R. Stone, 2014 .

Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia.

J. Radich, R. Larson, F. Appelbaum, 2020, JCO oncology practice.

Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.

F. Appelbaum, T. Bochtler, U. Hegenbart, 2013, Blood.

Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia

B. Wood, B. Sandmaier, F. Appelbaum, 2022, Haematologica.

SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome–Negative B-Cell Acute Lymphoblastic Leukemia

B. Wood, C. Willman, W. Stock, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia.

E. Estey, M. Bar, B. Wood, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Substantial inter-individual and limited intra-individual genomic diversity among tumors from men with metastatic prostate cancer

J. Shendure, P. Nelson, N. Schultz, 2016, Nature Medicine.

Adult Low-Hypodiploid Acute B-Lymphoblastic Leukemia With IKZF3 Deletion and TP53 Mutation: Comparison With Pediatric Patients.

Ankita Patel, F. Appelbaum, K. Eaton, 2015, American journal of clinical pathology.

Cyclophosphamide promotes engraftment of gene-modified cells in a mouse model of Fanconi anemia without causing cytogenetic abnormalities

H. Kiem, G. Trobridge, P. Becker, 2012, Journal of Molecular Medicine.

Treosulfan, Fludarabine and 2 Gy Total Body Irradiation Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with MDS and AML

E. Estey, M. Bar, B. Wood, 2014 .

SWOG S1203: A Randomized Phase III Study of Standard Cytarabine Plus Daunorubicin (7+3) Therapy Versus Idarubicin with High Dose Cytarabine (IA) with or without Vorinostat (IA+V) in Younger Patients with Previously Untreated Acute Myeloid Leukemia (AML)

J. Radich, R. Larson, F. Appelbaum, 2016 .

Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancer

P. Nelson, J. Davison, R. Vessella, 2016, Epigenetics.

Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for MDS and AML evolving from MDS

H. Deeg, B. Sandmaier, T. Gooley, 2016 .

Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia.

E. Estey, B. Wood, M. Sorror, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin

M. Fang, S. Xiao, Long-fei Liu, 2015, Journal of Cancer Research and Clinical Oncology.

A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancer.

P. Nelson, R. Vessella, L. True, 2013, Cancer genetics.

A Three-Marker FISH Panel Detects More Genetic Aberrations of AR, PTEN and TMPRSS2/ERG in Castration-Resistant or Metastatic Prostate Cancers than in Primary Prostate Tumors

P. Nelson, R. Vessella, C. Higano, 2013, PloS one.

Genomic Profiling Defines Subtypes of Prostate Cancer with the Potential for Therapeutic Stratification

M. Fang, J. Schoenborn, P. Nelson, 2013, Clinical Cancer Research.

CGH-based microarray detection of cryptic and novel copy number alterations and balanced translocations in cytogenetically abnormal cases of b-cell all

U. Surti, L. Shaffer, Y. Ning, 2013 .

PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles

P. Nelson, Jian-Bing Fan, J. Stanford, 2017, Oncotarget.

Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic Aberrations

Nolan G. Ericson, J. Bielas, J. Delrow, 2016, Molecular Cancer Research.

Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials

E. Estey, J. Davison, S. Meshinchi, 2017, Cancer.

Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia

E. Estey, J. Davison, S. Heimfeld, 2015, Epigenetics.

Lamin B1 deletion in myeloid neoplasms causes nuclear anomaly and altered hematopoietic stem cell function.

E. Estey, J. Abkowitz, Z. Duan, 2022, Cell stem cell.

Chronic Myelogenous Leukemia Presenting in Blast Phase with Nodal, Bilineal Myeloid Sarcoma and T-Lymphoblastic Lymphoma in a Child

David Wu, K. Opheim, J. Rutledge, 2013, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

Clinical Utility of Chromosome Genomic Array Testing for Unclassified and Advanced-Stage Renal Cell Carcinomas.

M. Tretiakova, T. Antic, S. Tykodi, 2018, Archives of pathology & laboratory medicine.

A novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma

M. Fang, Weifeng Xu, Yuyan Yu, 2023, Frontiers in Genetics.

Cyclophosphamide promotes engraftment of gene-modified cells in a mouse model of Fanconi anemia without causing cytogenetic abnormalities

H. Kiem, G. Trobridge, P. Becker, 2012, Journal of Molecular Medicine.

Jumping translocations in myelodysplastic syndromes.

H. Deeg, David Wu, C. Pritchard, 2016, Cancer genetics.

Relapse after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Analysis of Late Relapse Using Comparative Karyotype and Chromosome Genome Array Testing.

T. Gooley, A. Gerds, H. Deeg, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High-Resolution Genomic Profiling of Disseminated Tumor Cells in Prostate Cancer.

P. Nelson, R. Vessella, P. Lange, 2016, The Journal of molecular diagnostics : JMD.

BPTF Associated with EMT Indicates Negative Prognosis in Patients with Hepatocellular Carcinoma

M. Fang, S. Xiao, Long-fei Liu, 2015, Digestive Diseases and Sciences.

Chromosomal microarray interpretation: what is a child neurologist to do?

A. Paciorkowski, M. Fang, 2009, Pediatric neurology.

Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report.

E. Estey, J. Radich, S. Meshinchi, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mutational profiling in acute lymphoblastic leukemia by RNA sequencing and chromosomal genomic array testing

M. Fang, J. Radich, X. Qu, 2021, Cancer medicine.

Prognostic significance of acquired copy‐neutral loss of heterozygosity in acute myeloid leukemia

E. Estey, B. Storer, F. Appelbaum, 2015, Cancer.

Comparison of four next generation sequencing platforms for fusion detection: Oncomine by ThermoFisher, AmpliSeq by illumina, FusionPlex by ArcherDX, and QIAseq by QIAGEN.

P. Nelson, M. Fang, Ilsa M. Coleman, 2019, Cancer genetics.

Mutational analysis in serial marrow samples during azacitidine treatment in patients with post-transplant relapse of acute myeloid leukemia or myelodysplastic syndromes

H. Deeg, B. Storer, Janghee Woo, 2017, Haematologica.

Comparative analysis of total body irradiation (TBI)-based and non-TBI-based myeloablative conditioning for acute myeloid leukemia in remission with or without measurable residual disease

B. Wood, B. Sandmaier, F. Appelbaum, 2019, Leukemia.

Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients

J. Radich, S. Meshinchi, D. Stirewalt, 2023, Biomarker Research.

Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics Consortium working group for plasma cell disorders.

Trevor J Pugh, T. Pugh, J. Fink, 2018, Cancer genetics.

Hematopoietic Cell Transplantation for Myelofibrosis: the Dynamic International Prognostic Scoring System Plus Risk Predicts Post-Transplant Outcomes.

H. Deeg, Emily A. Stevens, M. Sorror, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Factors Determining Responses to Azacitidine in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Early Post-Transplantation Relapse: A Prospective Trial.

H. Deeg, B. Storer, Janghee Woo, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation.

M. Sorror, R. Storb, F. Appelbaum, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience.

F. Appelbaum, M. Othus, D. Roulston, 2010, Blood.

Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia

E. Estey, F. Appelbaum, M. Othus, 2012, Haematologica.

Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia

F. Appelbaum, M. Othus, H. Erba, 2015, Haematologica.

Comparative Analysis of Total Body Irradiation (TBI)-Based and Non-TBI-Based Myeloablative Conditioning for Acute Myeloid Leukemia in Remission with and without Measurable Residual Disease

H. Deeg, B. Wood, B. Sandmaier, 2019, Blood.

Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia

E. Estey, J. Radich, R. Walter, 2023, Leukemia & lymphoma.

Results of SWOG 1318: A Phase 2 Trial of Blinatumomab Followed By Pomp (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) Maintenance in Elderly Patients with Newly Diagnosed Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic Leukemia

B. Wood, W. Stock, R. Stone, 2018, Blood.